Xavier Cathelineau

Xavier Cathelineau

Auto-generated profile, based on publicly available information

Xavier Cathelineau

Institut Mutualiste Montsouris, University Paris-Descartes, Paris, France

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2014 in Current Opinion in Urology
Verified
Journal Article
Closed access
EBEric Barret
Eric Barret
KHKadi-Ann Harvey-Bryan
Kadi-Ann Harvey-Bryan
RSRafael Sanchez-Salas
Rafael Sanchez-Salas
FRFrancois Rozet
Francois Rozet
MGMarc Galiano
Marc Galiano
XCXavier Cathelineau
Xavier Cathelineau
Focal therapy presents an alternative option for disease-targeted therapy while preserving erectile and urinary function without compromising oncological outcome. Such treatment, which preserves normal prostate parenchyma, presents a clinical challenge to the urologist, as typical disease surveillance parameters are not as reliable in post-ablation follow-up. We propose an integrated approach to post-ablation surveillance to identify treatment failure as well as recurrence. Post-ablation prostate-specific antigen kinetics, imaging based on multiparametric MRI and control biopsies are the tools currently used to follow patients after focal therapy. Good treatment response is indicated by a negative control biopsy, absence of persistent lesion on post-treatment imaging and a reduction in prostate-specific antigen of at least 50%. When histological evidence of therapeutic failure or recurrence is present, different options of management may be proposed to the patient including active surveillance, focal salvage therapy or radical salvage treatment, depending on the characteristics of the lesion found. A recommended post-ablation surveillance protocol is presented as well as a discussion of management strategies based on the data currently available.

1 December 2002
Verified
Journal Article
Closed access
GVGuy Vallancien
Guy Vallancien
HFHazem Abou El Fettouh
Hazem Abou El Fettouh
XCXavier Cathelineau
Xavier Cathelineau
HBHerve Baumert
Herve Baumert
GFGaelle Fromont
Gaelle Fromont
BGBertrand Guillonneau
Bertrand Guillonneau
To minimize the risk of incontinence and impotence without compromising oncological outcome, we performed prostate sparing surgery during radical cystectomy for bladder cancer. Since 1992, 100 patients with a mean age of 64 years (range 48 to 82) underwent cystectomy for bladder transitional cell carcinoma with prostate sparing based on normal digital rectal examination of the prostate, normal prostate specific antigen (PSA), percent free PSA greater than 15 and normal transrectal ultrasound of the prostate. Prostate biopsies to exclude prostate cancer were performed on patients with an abnormal digital rectal examination, high PSA, percent free PSA less than 15 or hypoechoic lesions on ultrasound. Surgery consisted of transurethral resection of the prostate with analysis of frozen section of the prostatic urethra and transitional prostate and cystectomy with reconstruction by a Z ileal bladder anastomosed to the prostatic capsule after confirmation of the absence of prostate or bladder cancer on frozen sections of the surgical capsule specimens. Patients were followed closely with imaging and laboratory studies every 6 months and annually for 3 years thereafter. Perioperative death occurred in 1 patient due to septicemia, 20 patients (20%) died of cancer and 6 (6%) died of nonrelated cancer causes. Mean followup 38 months (range 2 to 111). Postoperative pathological stage was PT0 in 2 cases, PtaT1 in 22, PT2 in 48, PT 3 in 28 and N+ in 13. The 5-year actuarial global survival according to pathological stage was pTaT1N0 in 96% of cases, pT2N0 in 83%, pT3N0 in 71% and N+ in 54% (p = 0.0001). The 5-year actuarial cancer specific survival was PT0, Ta T1 in 90% of cases, PT2 in 73%, PT3 in 63% and N- in 8%. The cancer specific survival according to pathological grade was 100% for well differentiated tumors (grade I), 76% for moderately differentiated tumors (grade II) and 47% for poorly differentiated tumors (grade III) (p = 0.003). Local recurrence was pTaT1N0 in 1 of 22 cases (4.5%), pT2N0 in 2 of 40 (5%), pT3N0 in 2 of 23 (8.5%) and N+ in 0 of 13 (0%). Prostate cancer was diagnosed in 3 patients (2 errors in the diagnosis and 1 cancer de novo within 5 years of followup). At 1-year followup 86 of 88 patients (97%) are fully continent (no pad) during the day, and 84 (95%) void 1 to 2 times a night to stay dry. Of 61 patients with previously adequate sexual function 50 (82%) maintained potency with retrograde ejaculation secondary to transurethral resection, 6 (10%) have partial potency and 5 (8.1%) are impotent. Cystectomy with prostate sparing for bladder cancer is feasible and offers promising functional results with no additional oncological risk. Careful selection of patients is mandatory.

24 December 2015 in Urology
Verified
Journal Article
Closed access
PDF file
MGMarc Galiano
Marc Galiano
CGCyrille Guillot-Tantay
Cyrille Guillot-Tantay
ASArjun Sivaraman
Arjun Sivaraman
HSHakim Slaoui
Hakim Slaoui
EBEric Barret
Eric Barret
XCXavier Cathelineau
Xavier Cathelineau

1 April 2010 in International braz j urol
Verified
Journal Article
Open access
PDF file
XCXavier Cathelineau
Xavier Cathelineau
RSRafael Sanchez-Salas
Rafael Sanchez-Salas
EBEric Barret
Eric Barret
FRFrancois Rozet
Francois Rozet
MGMarc Galiano
Marc Galiano
GVGuy Vallancien
Guy Vallancien
PURPOSE: To review the literature and present a current picture of the evolution in radical prostatectomy from the laparoscopic point of view. MATERIALS AND METHODS: We conducted an extensive Medline literature search. Articles obtained regarding laparoscopic radical prostatectomy (LRP) and our experience at Institut Montsouris were used for reassessing anatomical and technical issues in radical prostatectomy. RESULTS: LRP nuances were reassessed by surgical teams in order to verify possible weaknesses in their performance. Our basic approach was to carefully study the anatomy and pioneer open surgery descriptions in order to standardized and master a technique. The learning curve is presented in terms of an objective evaluation of outcomes for cancer control and functional results. In terms of technique-outcomes, there are several key elements in radical prostatectomy, such as dorsal vein control-apex exposure and nerve sparing with particular implications in oncological and functional results. Major variations among the surgical teams' performance and follow-up prevented objective comparisons in radical prostatectomy. The remarkable evolution of LRP needs to be supported by comprehensive results. CONCLUSIONS: Radical prostatectomy is a complex surgical operation with difficult objectives. Surgical technique should be standardized in order to allow an adequate and reliable performance in all settings, keeping in mind that cancer control remains the primary objective. Reassessing anatomy and a return to basics in surgical technique is the means to improve outcomes and overcome the difficult task of the learning curve, especially in minimally access urological surgery.

1 August 2012
Verified
Journal Article
Closed access
NCNathalie Cathala
Nathalie Cathala
AMAnnick Mombet
Annick Mombet
RSRafael Sanchez-Salas
Rafael Sanchez-Salas
FRFrancois Rozet
Francois Rozet
EBEric Barret
Eric Barret
GVGuy Vallancien
Guy Vallancien

1 November 2004
Verified
Journal Article
Closed access
MGMarc Galiano
Marc Galiano
FDFabrice Dugardin
Fabrice Dugardin
FRFrançois Rozet
François Rozet
XCXavier Cathelineau
Xavier Cathelineau
GVGuy Vallancien
Guy Vallancien